These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18625002)

  • 1. Rimonabant: a rapidly expanding role in the management of metabolic and systemic disorders besides polycystic ovarian syndrome.
    Kapoor S
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):339. PubMed ID: 18625002
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome.
    Sathyapalan T; Dakroury Y; Ahmed L; Elshewehy AM; Kilpatrick ES; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):671-3. PubMed ID: 27256522
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoid CB1 receptor antagonists for atherosclerosis and cardiometabolic disorders: new hopes, old concerns?
    Pacher P
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):7-9. PubMed ID: 19092136
    [No Abstract]   [Full Text] [Related]  

  • 4. Rimonabant: obituary for a wonder drug.
    Boekholdt SM; Peters RJ
    Lancet; 2010 Aug; 376(9740):489-90. PubMed ID: 20709215
    [No Abstract]   [Full Text] [Related]  

  • 5. Rimonabant: suicide and depression. Depression and suicidal tendencies are about twice as frequent with rimonabant as with placebo.
    Prescrire Int; 2007 Dec; 16(92):250. PubMed ID: 18092422
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of rimonabant on weight reduction and cardiovascular risk.
    van Oosten B; Killestein J; Polman Ch
    Lancet; 2005 Jul 30-Aug 5; 366(9483):368-9; author reply 369-70. PubMed ID: 16054933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rimonabant. Risk of depression has not been finally clarified].
    Kreutzkamp B
    Med Monatsschr Pharm; 2008 May; 31(5):191-2. PubMed ID: 18552079
    [No Abstract]   [Full Text] [Related]  

  • 8. The cardiometabolic drug rimonabant: after 2 years of RIO-Europe and STRADIVARIUS.
    Kintscher U
    Eur Heart J; 2008 Jul; 29(14):1709-10. PubMed ID: 18556715
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of rimonabant on weight reduction and cardiovascular risk.
    Hirschel B
    Lancet; 2005 Jul 30-Aug 5; 366(9483):369; author reply 369-70. PubMed ID: 16054934
    [No Abstract]   [Full Text] [Related]  

  • 10. New diet drug stirs high hopes. But can the pill, rimonabant, liver up to large expectations?
    Heart Advis; 2005 Feb; 8(2):3. PubMed ID: 15806687
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of rimonabant and metformin on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in obese women with polycystic ovary syndrome.
    Sathyapalan T; Cho L; Kilpatrick ES; Le Roux CW; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):423-5. PubMed ID: 19489873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cannabinoid receptor blocker rimonabant. CNS side effects prevent U.S. approval].
    MMW Fortschr Med; 2007 Jun; 149(27-28):8. PubMed ID: 17717874
    [No Abstract]   [Full Text] [Related]  

  • 13. [In diabetes cannabinoid antagonist kills two birds with one stone].
    MMW Fortschr Med; 2005 Sep; 147(35-36):10. PubMed ID: 16180564
    [No Abstract]   [Full Text] [Related]  

  • 14. Rimonabant induces partial seizures in a patient with a history of generalized epilepsy.
    Braakman HM; van Oostenbrugge RJ; van Kranen-Mastenbroek VH; de Krom MC
    Epilepsia; 2009 Sep; 50(9):2171-2. PubMed ID: 19706063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prescription of rimonabant in the early stage of pregnancy?].
    Picksak G; Stichtenoth DO
    Med Monatsschr Pharm; 2008 Mar; 31(3):107-8. PubMed ID: 18429532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
    Van Gaal LF; Scheen AJ; Rissanen AM; Rössner S; Hanotin C; Ziegler O;
    Eur Heart J; 2008 Jul; 29(14):1761-71. PubMed ID: 18417461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hope and fear of rimonabant.
    Rumsfeld JS; Nallamothu BK
    JAMA; 2008 Apr; 299(13):1601-2. PubMed ID: 18387935
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
    Després JP; Golay A; Sjöström L;
    N Engl J Med; 2005 Nov; 353(20):2121-34. PubMed ID: 16291982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New drugs; rimonabant].
    van Bronswijk H; Dubois EA; Pijl H; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2620-2. PubMed ID: 18161263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and weight loss: opposite outcome for surgery and rimonabant?
    Chaput JP; Tremblay A
    Obes Rev; 2008 Sep; 9(5):504-7. PubMed ID: 18643944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.